Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

KTTA

Pasithea Therapeutics Corp

May 22 • 04:00PM ET

0.6998

-0.0212 -2.94 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: NRXP NERV ADIL ALZN DMAC

| Held by: PSIL VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.07	Insider Own	11.37%	Shs Outstand	24.94M	Perf Week	-10.29%
Market Cap	23.38M	Forward P/E	-	EPS next Y	-1.01	Insider Trans	5.56%	Shs Float	22.10M	Perf Month	1.52%
Enterprise Value	-27.12M	PEG	-	EPS next Q	-0.12	Inst Own	70.48%	Short Float	1.21%	Perf Quarter	-15.28%
Income	-19.73M	P/S	-	EPS this Y	73.88%	Inst Trans	27.83%	Short Ratio	0.65	Perf Half Y	47.05%
Sales	0.00M	P/B	0.32	EPS next Y	-32.89%	ROA	-55.58%	Short Interest	0.27M	Perf YTD	-45.75%
Book/sh	2.20	P/C	0.46	EPS next 5Y	23.55%	ROE	-58.22%	52W High	2.06 -66.03%	Perf Year	-25.63%
Cash/sh	1.51	P/FCF	-	EPS past 3/5Y	35.92% -117.71%	ROIC	-36.00%	52W Low	0.28 149.04%	Perf 3Y	-89.71%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.83% 7.19%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	80.42%	Oper. Margin	-	ATR (14)	0.05	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	35.40	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	39.05	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	35.40	EPS Q/Q	92.68%	SMA20	-8.62%	Beta	0.24	Target Price	3.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	-8.08%	Rel Volume	0.81	Prev Close	0.72
Employees	5	LT Debt/Eq	0.00	Earnings	Feb 25	SMA200	-14.32%	Avg Volume	412.20K	Price	0.70
IPO	Sep 15, 2021	Option/Short	No / Yes	EPS/Sales Surpr.	-338.89% -	Trades		Volume	333,925	Change	-2.94%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)